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A 2-year-old intact female miniature Pinscher weighing 1.7 kg with a body condition score of 2/5 was presented
for acute vomiting, lethargy for 2 days, and large petechial skin lesions on the hip region including the tail. Acute
pancreatitis was diagnosed by clinical signs, strong positive cPLI test, laboratory test and ultrasound appearance.
While the clinical signs associated with acute pancreatitis had improved in 3–5 days, lesion of petechial appeared
on the left hip region 7 days after the presentation, with a fast progression into a necrotic tissue along the left side
hip. Allogenic platelet rich plasma (PRP) with Weibrich and Kleis method was administered to promote skin healing
and regeneration. Gradual and complete improvement in the dog’s wound lesions was noted approximately 1 month
after applying allogeneic topical PRP. In this case report, allogeneic PRP was applied to a large regional cutaneous defect
caused by coagulopathy induced by acute pancreatitis. Topical application of PRP in this case was unique in that
allogeneic PRP was used instead of autologous PRP for the first time in cutaneous soft-tissue wound management in
the veterinary medical field.
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Disseminated intravascular coagulopathy (DIC) is a
complex set of events that arises when there is excess
intravascular coagulation causing multiple-organ micro-
thrombosis and paradoxical bleeding including the skin
[1]. The bleeding is caused by either inactivation or ex-
cess consumption of platelets and/or clotting factors be-
cause of increased fibrinolysis and may have a gradual or
acute onset. Once this process starts, changes in the pa-
tient’s status occur rapidly and require intense monitor-
ing with subsequent changes in therapy as indicated [2].
The classic cutaneous manifestations of DIC present as
skin wounds such as bruising, contusions, petechiae,
purpura, acral cyanosis, hemorrhagic bullae, purpura* Correspondence: chulpark0409@jbnu.ac.kr
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unless otherwise stated.fulminans, subcutaneous dissecting hematomata, or bleed-
ing from wound or venipuncture sites [3].
Cutaneous wound healing requires a complex balance
between matrix elements and growth factors and is
dependent on multiple variables, including blood supply,
defect size, tension, and mobility that affect the rates of
healing and residual scarring [4]. Platelet rich plasma
(PRP) not only enhances wound healing but also helps
regenerate skin tissue [5]. Autologous PRP enhances
wound healing and tissue regeneration and has been used
as a source of growth factors in bone fracture treatment
and in general wound healing for skin defects or dental
mucosal wound care [6-8]. However, the current method
of applying PRP for skin recovery used in veterinary stud-
ies is limited to autologous PRP applications [9,10].
This report describes a very small patient (toy
breed, < 2 kg) with a large skin defect including the tail
and subsequent use of topical allogeneic PRP as adjunct
therapy.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Specific hematology, serum chemistry, and
coagulation profile data of a dog with disseminated
intravascular coagulation associated with pancreatitis
Hematology Value Reference interval
WBC 19.41 6 ~ 12 (10x9/L)
WBC-Lymph(#) 1.1 1 ~ 3.6 (10x9/L)
WBC-Lymph(%) 5.8 0 ~ 100 (%)
WBC-Mono(#) 0.6 0 ~ 0.5 (10x9/L)
WBC-Mono(%) 3.2 0 ~ 100 (%)
WBC-Gran(#) 17.7 3 ~ 10 (10x9/L)
WBC-Gran(%) 91 0 ~ 100 (%)
WBC-Eos(%) 1.1 ~ (%)
RBC 6.89 5.5 ~ 8.5 (10x12/L)
Hemoglobin[Hb] 15.69 15 ~ 20 (g/dL)
Hematocrit[Hct] 48.13 37 ~ 54 (%)
MCV 70 60 ~ 77 (fL)
MCH 22.77 17 ~ 23 (pg)
MCHC 32.61 31 ~ 36 (g/dL)
RDW-CV 14.43 14 ~ 17 (%)
Platelet 66 200 ~ 460 (10x9/L)
MPV 8.37 6.7 ~ 11.1 (fL)
Serum chemistry Value Reference interval
Albumin 2.2 2.2 ~ 3.9 (g/dL)
ALKP 159 23 ~ 212 (U/L)
ALT 61 10 ~ 100 (U/L)
Amylase 2500 500 ~ 1500 (U/L)
BUN 50 7 ~ 27 (mg/dL)
Calcium[Ca++] 8.4 7.9 ~ 12 (mg/dL)
Cholesterol-Total 200 110 ~ 320 (mg/dL)
Creatinine 0.4 0.5 ~ 1.8 (mg/dL)
Glucose 83 77 ~ 125 (mg/dL)
Phosphorus-Inorganic 3.4 2.5 ~ 6.8 (mg/dL)
Bilirubin-Total 1 0 ~ 0.9 (mg/dL)
Protein-Total 6.1 5.2 ~ 8.2 (g/dL)
Coagulation panel Value Reference interval
Whole blood APTT 99 60 ~ 93 (sec)
Whole blood PT 15.5 11 ~ 14 (sec)
D-dimer 0.7 0.1 ~ 0.5 (mg/dL)
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A 2-year-old intact female miniature Pinscher weighing
1.7 kg with a body condition score of 2 out of 5 was pre-
sented for acute vomiting, lethargy for 2 days, and large
petechial skin lesions on the hip region including the
tail. The dog was primarily diagnosed with acute pan-
creatitis based on clinical signs, strong positive cPLI test
and abdominal ultrasound. The treatment was initiated
mainly with fluid therapy (0.9% normal saline) and fresh
frozen plasma (10 ml/kg) concurrently with other
supportive treatment, including analgesics (Tramadol,
3 mg/kg, IV), antiemetics (Maropitant, 1 mg/kg, SQ),
and H2-blockers (Ranitidine, 2 mg/kg, IV). While the
clinical signs associated with acute pancreatitis had been
improved in 3–5 days, lesion of petechial appeared on
the left hip region 7 days after the presentation, with a
fast progression into a necrotic tissue along the left side
hip. The concurrent cutaneous manifestation of systemic
DIC was recognized according to diagnostic references
[11] by the acute pancreatitis diagnosis and laboratory
results showing a low platelet count, prolonged blood
clotting time, and increased fibrin degradation products
such as D-dimer (Table 1). The skin lesions were diag-
nosed as small petechiea that appeared on the left stifle
on the first day of presentation, with fast progression to
necrotic tissue along the left side of hip within the 3 days.
Initial treatments included debridement and warm
saline washes with systemic cephalexin twice per day
(Cephalexin; Ildong Pharm Co., Ltd. Seoul, South
Korea) to protect against secondary infection. The lesions
had not improved 5 days after the acute pancreatitis signs
had improved (Figure 1a). Allogeneic PRP was added to
the conventional treatments to promote skin healing and
regeneration on day 5 because autologous PRP was im-
possible due to the patient’s low body mass (<2 kg, toy
breed). The basic protocol to prepare the PRP was based
on the Weibrich and Kleis method [12]. The PRP applied
in this case was allogeneic PRP, instead of autologous
PRP, in which the PRP blood source was from a donor
dog (5-year-old intact healthy female beagle). Except for
this difference, the other procedures for preparing the
PRP were similar to those of the Weibrich and Kleis
method, in which the donor’s blood (8 mL) was drawn
into a citrate tube and centrifuged for 10 minutes at
629 × g to separate the blood into two basic components
according to density (PRP in the top layer and red blood
cells and white blood cells in the bottom layer). The PRP
was carefully removed with a pipette and mixed with
200 μL of the lower layer, which contained large but
more recently synthesized platelets. The mixture was
centrifuged at 1,233 × g for 14 minutes to separate the
platelet pellet in the supernatant layer. Centrifugation
was repeated until the PRP mixture was obtained, includ-
ing 0.6–0.7 mL of supernatant and a mean plateletconcentration of 1.0–1.2 × 10 [6] platelets/μL. The PRP
was mixed with an equal volume of sterile saline solution
and 10% calcium chloride. The topical PRP gel (0.1 mL)
was applied to the hip lesion, supplemented with erythro-
poietin (Epokine, Pharma CJ Cheiljedang, Icheon-si,
Republic of Korea) and granulocyte colony-stimulating
factor (Leukokine, Pharma CJ Cheiljedang, Icheon-si,
Republic of Korea) for active hematopoiesis while con-
tinuing debridement and saline cleansing. Two days after
Figure 1 Clinical improvement of lesions on (a) Day0, (b) Day2, (c) Day5, (d) Day13, (e) Day21 and (f) Day28 after topical PRP application.
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and granulation tissue began to grow (Figure 1b). The le-
sions improved in color and mild regression in size was
observed 5 days after applying the PRP (Figure 1c). The
defect regressed significantly, almost by half in diameter,
13 days after applying the topical PRP (Figure 1d). Four
weeks after the first presentation and 3 weeks after the
first PRP application, the wound had significantly regen-
erated with healthy granulation tissue and was almost
completely healed with epithelialization (Figure 1e). The
skin lesions had almost completely regenerated 25 days
after the allogeneic PRP application, which was 30 days
after the first presentation of the skin lesion. A marked
reduction in swelling, lack of crusts and erosion, and hair
regrowth were observed (Figure 1f ). This case trial has
been carried out under the ethical guidelines of Chonbuk
University IACUC.
Conclusion
Studies on dogs and cats that have evaluated the ability
of allogeneic PRP to heal cutaneous wound and regener-
ate tissue are extremely rare [5]. Conventional treat-
ments for chronic wounds including topical steroids and
antibiotics with changes of dressings and debridementsometimes do not effectively promote the wound-
healing cascade as in the present case induced by DIC
associated with acute pancreatitis. Although randomized
controlled studies are extremely rare for DIC-induced
skin defects associated with acute pancreatitis, PRP and
platelet gels are increasingly being used for therapeutic
tissue regeneration, as evidenced by several published
clinical and experimental reports in human medicine.
PRP was applied to the non-healing wounds based on
its potential to enhance healing of large wounds, and
gradual and complete improvement in the patient’s tail
lesion was noted approximately 1 month after applying
the allogeneic topical PRP. Various hematological ab-
normalities including decreased serial hemoglobin or
hematocrit values, coagulation factor abnormalities,
leukocytosis, acute hemolytic anemia, thrombocytopenia,
and thrombotic thrombocytopenic purpura or hemolytic
uremic syndrome have been reported in patients with
acute pancreatitis [13]. Similarly, abnormalities in blood
coagulation factors consistent with DIC have also been de-
tected in patients with pancreatitis.
PRP is a plasma fraction, in which platelet-derived
growth factor and transforming growth factor-β are
thought to be concentrated. PRP contains other autologous
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accelerating tissue regeneration. In the present case, the
patient was too small with a poor body condition score of
2/5 and body fluid volume was extremely low due to dehy-
dration to take blood to prepare autologous PRP. Gradual
and complete improvement in the dog’s wound lesion was
noted approximately 1 month after applying allogeneic
topical PRP using a similar treatment period as that for au-
tologous PRP [9]. Results showed an equally potent efficacy
for wound healing as that of autologous PRP. This finding
could open a new field of wound healing therapy, particu-
larly in dogs with microangiopathy or coagulopathy and
hormonal defects.
PRP is a cost-effective and readily available therapeutic
blood derivative that is rich in growth factors and cyto-
kines and increases tissue regeneration by affecting cell
recruitment, proliferation, and differentiation. Applying
allogeneic PRP topically to treat skin vascular defect-
associated problems may be particularly effective be-
cause of the high leukocyte concentration, which results
in local debridement and antibacterial activity without a
rejection reaction in this case, particularly in toy breed
dogs with a small body mass and fluid volume. Further
studies with a larger number of samples in controlled
clinical trials are required to elucidate a clear mechan-
ism of action and identify possible adverse effects of
using PRP for this application.
In conclusion, we demonstrated that topical treatment
with allogeneic PRP is a safe adjunct therapy for skin
wound healing. Allogeneic PRP may be particularly
beneficial to manage large skin defects in toy breed
dogs that are induced by DIC associated with acute
pancreatitis.
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